Your browser doesn't support javascript.
loading
Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2-positive breast carcinomatous meningitis.
Hofer, Silvia; Aebi, Stefan.
Affiliation
  • Hofer S; Division of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland. Electronic address: silvia.hofer@luks.ch.
  • Aebi S; Division of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
Eur J Cancer ; 103: 279-280, 2018 11.
Article in En | MEDLINE | ID: mdl-30270111
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Meningeal Carcinomatosis Limits: Humans Language: En Journal: Eur J Cancer Year: 2018 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Meningeal Carcinomatosis Limits: Humans Language: En Journal: Eur J Cancer Year: 2018 Document type: Article Country of publication: United kingdom